Overview

Cytyc Surgical Products is a wholly owned subsidiary of Cytyc Corporation. Cytyc Surgical Products was formed in March 2004 after Cytyc Corporation acquired Novacept, Inc., a privately held company that was founded in 1995 with a focus on developing innovative therapeutic devices to improve the quality of women's healthcare.

Cytyc Surgical Products' flagship product is the NovaSure® Impedance Controlled Endometrial Ablation System, a patented next generation technology that treats excessive menstrual bleeding, medically known as menorrhagia, due to benign causes. The NovaSure System provides a superior clinical solution to other products presently on the market or in development, as it is a quick, simple, safe and complete procedure that averages only 90 seconds.

If you or a loved one suffer from excessive menstrual bleeding and would like more information on the NovaSure System, please click here.

If you are a physician who would like more information on the NovaSure System, please click here.

The NovaSure System is currently available for sale in Canada, Europe, Australia and the United States.